[Desensitisation with hymenoptera venom in children]

Area of Science:

• Allergy and Immunology
• Pediatric Medicine
• Immunotherapy

Context:

• Hymenoptera venom immunotherapy is established in adults.
• Limited data exists on its use and outcomes in pediatric populations.
• Accelerated desensitization protocols are increasingly utilized.

Purpose:

• To evaluate the clinical tolerance and immunological consequences of hymenoptera venom immunotherapy in children.
• To compare outcomes in children with those in adult patients undergoing similar treatment.
• To assess the efficacy of immunotherapy in children with bee and wasp venom hypersensitivity.

Summary:

• This study compared children (n=18) and adults (n=33) undergoing accelerated hymenoptera venom immunotherapy.
• Children demonstrated superior clinical tolerance to identical venom doses compared to adults.
• Immunotherapy showed similar efficacy in both age groups, with children exhibiting greater specific IgG increase and specific IgE decrease (bee venom).

Impact:

• Findings suggest hymenoptera venom immunotherapy is safe and effective in pediatric patients.
• The study highlights potential immunological advantages of immunotherapy in children.
• Results support the use of accelerated desensitization protocols for venom hypersensitivity in children.